95% accuracy for LVO stroke diagnosis

A point-of-care diagnostic solution powered by advanced blood-based biomarkers for brain injuries. LVOCheck is designed for the selection and triage of large vessel occlusion (LVO) stroke patients to identify those requiring rapid treatment. The platform utilizes proprietary Software as a Medical Device technology to differentiate between ischemic and haemorrhagic stroke and detect mild traumatic brain injury.

Automated immunoassay system for rapid blood-based diagnosis of traumatic brain injury using dual biomarkers (GFAP and UCH-L1). The VEUS platform delivers results within 15-50 minutes with high sensitivity and multiplexing capability, utilizing magnetic particle technology for accurate point-of-care neurological assessment.

A rapid biochemical test that differentiates between ischemic stroke and intracranial hemorrhage within the first 4 hours from symptom onset. The test uses a combination of biomarkers to provide accurate diagnosis for stroke subtype determination, enabling rapid decision-making at point-of-care settings including ambulances and primary hospitals. This allows for timely initiation of specific treatment protocols such as reperfusion therapies.

VELLAP rapid tests are lateral flow assay (LFA) diagnostic tests designed for professional clinical use, enabling quick and reliable point-of-care diagnosis across healthcare, veterinary, and environmental applications. The platform supports therapeutic decision-making through validated, component-optimized test design with optional digital quantification via VELLAP SCAN mobile application.

Rapid diagnostic test for detecting large vessel occlusion in acute ischemic stroke patients using brain biomarkers. Enables fast clinical validation and patient stratification to guide immediate intervention decisions in stroke management.

A fully automated assay for measurement of neurofilament light chain in blood samples. This CE-marked test supports diagnosis and monitoring of neurological disorders including multiple sclerosis, Parkinson's disease, and ALS.

Lateral flow immunochromatographic assay for qualitative detection of blood-borne viruses including dengue, COVID-19, influenza A/B, and RSV. Point-of-care rapid diagnostic test enabling quick differential diagnosis in clinical, hospital, and community settings. ISO13485 certified manufacturing ensures consistent quality and reliability for in-vitro diagnostic applications.

Lodestar DX is a rapid point-of-care molecular diagnostic system for urinary tract infection testing, delivering results in 35 minutes with up to 97% accuracy in detecting the six most common UTI pathogens. The system enables clinicians to rule out UTIs at the bedside, facilitating targeted antibiotic therapy and reducing unnecessary prescriptions while minimizing sepsis risk from delayed diagnosis.

Point-of-care rapid diagnostic tests delivering accurate results within minutes. Enables faster diagnoses and better-informed clinical treatment decisions across multiple disease areas.

A microfluidic-based cardiovascular diagnostic test system providing lab-level accuracy for point-of-care testing. Designed for quick cardiovascular assessment using the mLabs® platform technology.

Lumi Go is a camera-based lateral flow reader for rapid optical analysis of diagnostic test strips across healthcare, food, and water quality applications. The device provides automated result interpretation with customizable algorithms and integrates with laboratory information systems via secure cloud connectivity for data management and regulatory compliance.

Rapid diagnostic tests that produce accurate results in minutes for point-of-care and clinical settings to enable faster diagnoses and improved patient outcomes.